Skip to main content
Premium Trial:

Request an Annual Quote

Blurry Lines and the Cost Curve

"The line between computing and biology has begun to blur," says this New York Times article focusing on Complete Genomics' efforts to offer cheaper sequencing through the combination of biology, chemistry, and computing. The Times says that Complete Genomics' origin is "a classic Silicon Valley start-up story" — an entrepreneur with a background in physics and math partnering with an optical physicist to start a company that offers sequencing as a service, rather than selling machines. Of course, Complete Genomics has a number of competitors. The Times notes that "because there is no clear winner yet, all of the companies are pushing hard to get down the cost curve as fast as possible."

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.